Table 4.
Development of a prognostic scoring model
| Variables | Prognostic scoring model 1 | Prognostic scoring model 2 |
|---|---|---|
| Male | 1 point | 3 points |
| Age ≥ 70 years | 1 point | 2 points |
| Malignancya | 1 point | 2 points |
| BMI <18.5 kg/m2 | 1 point | 2 points |
| Lymphocytes <1000/μL | 1 point | 2 points |
| Alb <3.5 g/dL | 1 point | 4 points |
| FC pattern | 1 point | 2 points |
| Total scores | ||
| Risk groups | Prognostic scoring model 1 | |
| Low-risk | 0 − 1 point | |
| Intermediate-risk | 2 − 3 points | |
| High-risk | ≥4 points | |
95% CI 95% confidence interval, HR hazard ratio, BMI body mass index, Alb albumin, FC fibrocavitary disease
aMalignancy included lung cancer